PSTV Stock Analysis: Buy, Sell, or Hold?
PSTV - PLUS THERAPEUTICS, Inc. Common Stock
$5.42
-0.05 (-0.91%)
▼
5d:
-18.37%
30d:
-13.97%
90d:
+1656.32%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 29, 2026
0d
Get Alerted When PSTV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called PSTV this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PSTV is down 18.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PSTV is down 18.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PSTV is currently trading at $5.42, which is considered oversold relative to its 30-day fair value range of $5.63 to $6.41.
Technical Outlook: Technically, PSTV is in a strong uptrend. Immediate support is located at $5.21, while resistance sits at $7.30.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $38.00 (+601.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PSTV is in a strong uptrend. Immediate support is located at $5.21, while resistance sits at $7.30.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $38.00 (+601.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.63 -
$6.41
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 601.1% below Wall St target ($38.00)
- WARNING: Recommendation downgraded due to -18.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$5.63 -
$6.41
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$5.21
Resistance Level
$7.30
Current Trend
Strong Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.29
Wall Street Target
$38.00
(+601.1%)
Revenue Growth (YoY)
-3.2%
Share & Embed Analysis
Last updated: June 03, 2026 7:40 PM ET
Data refreshes hourly during market hours. Next update: 8:40 PM
Data refreshes hourly during market hours. Next update: 8:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PSTV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 66 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 55 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 53 HOLD |
